NYSE · Financial Statements

U.S. Physical Therapy, Inc. (USPH) Revenue, Earnings & Financial Statements

$97.34 NYSE: USPH Market Cap $1.45B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

U.S. Physical Therapy, Inc. most recently reported annual revenue of $781.0M, net profit of $15.0M. Revenue grew at an average annual rate of 13.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

U.S. Physical Therapy, Inc.: Revenue rose from $357.0M in 2016 to $781.0M in 2025, a change of +118.8% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 13.9% to 10.3%, a shift of -3.6 percentage points; the most recent year shows net profit of $15.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$357.0M$414.0M$454.0M$482.0M$423.0M$495.0M$553.0M$605.0M$671.0M$781.0M
Operating Expenses$307.0M$359.0M$394.0M$415.0M$371.0M$424.0M$496.0M$553.0M$608.0M$701.0M
Operating Profit$50.0M$55.0M$60.0M$67.0M$52.0M$71.0M$57.0M$52.0M$63.0M$80.0M
Operating Margin13.9%13.2%13.3%14.0%12.4%14.3%10.3%8.6%9.4%10.3%
Other Income−$11.0M−$21.0M$0$3.0M$13.0M$3.0M−$1.0M−$3.0M−$3.0M−$3.0M
Interest$11.0M$21.0M$2.0M$2.0M$2.0M$1.0M$6.0M$9.0M$8.0M$9.0M
Depreciation$9.0M$10.0M$10.0M$10.0M$11.0M$12.0M$15.0M$16.0M$19.0M$22.0M
Profit Before Tax$38.0M$34.0M$60.0M$71.0M$66.0M$73.0M$56.0M$49.0M$60.0M$78.0M
Tax rate (%)31.1%17.9%18.9%19.3%19.9%20.9%21.9%24.6%24.3%25.5%
Net Profit$21.0M$22.0M$10.0M$28.0M$31.0M$28.0M$28.0M$15.0M$26.0M$15.0M
EPS$1.64$1.76$0.80$4.49$4.09$4.49$3.34$1.28$1.84$1.42

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$155.0M$156.0M$167.0M$168.0M$180.0M$153.0M$164.0M$164.0M$203.0M$198.0M$214.0M$223.0M
Operating Expenses$156.0M$141.0M$152.0M$153.0M$166.0M$133.0M$139.0M$139.0M$181.0M$183.0M$192.0M$197.0M
Operating Profit−$1.0M$15.0M$16.0M$15.0M$15.0M$20.0M$25.0M$25.0M$22.0M$15.0M$22.0M$25.0M
Operating Margin-0.6%9.6%9.3%8.8%8.1%12.9%15.2%15.4%10.9%7.5%10.3%11.3%
Interest$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$3.0M$3.0M$4.0M
Profit Before Tax$0$15.0M$15.0M$12.0M$18.0M$17.0M$23.0M$23.0M$15.0M$11.0M$19.0M$22.0M
Tax rate (%)1319.8%21.3%20.8%20.7%31.8%22.3%21.8%22.9%38.7%22.8%21.8%18.4%
Net Profit−$8.0M$7.0M$7.0M$6.0M$7.0M$10.0M$9.0M$7.0M−$11.0M−$4.0M$2.0M$11.0M
EPS−$0.38$0.46$0.47$0.39$0.52$0.80$0.58$0.48−$0.44−$0.12$0.25−$1.04

Over the 10 years reported for U.S. Physical Therapy, Inc., borrowings increased from $52.0M in 2016 to $426.0M in 2025, cash stood at $36.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.01 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$351.0M$419.0M$443.0M$561.0M$594.0M$749.0M$858.0M$997.0M$1.2B$1.2B
Current Assets$66.0M$77.0M$79.0M$85.0M$88.0M$95.0M$111.0M$233.0M$138.0M$140.0M
Cash$20.0M$22.0M$23.0M$24.0M$33.0M$29.0M$32.0M$153.0M$41.0M$36.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$41.0M$50.0M$51.0M$56.0M$51.0M$62.0M$69.0M$70.0M$86.0M$88.0M
Fixed Assets$19.0M$20.0M$20.0M$104.0M$103.0M$119.0M$128.0M$130.0M$166.0M$271.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments−$3.0M−$2.0M−$2.0M$0$0$12.0M$12.0M$12.0M$12.0M$12.0M
Other Assets$227.0M$271.0M$294.0M$318.0M$346.0M$435.0M$494.0M$510.0M$667.0M$692.0M
Total Liabilities$93.0M$110.0M$92.0M$181.0M$184.0M$297.0M$374.0M$345.0M$408.0M$434.0M
Current Liabilities$25.0M$40.0M$42.0M$61.0M$93.0M$83.0M$85.0M$102.0M$116.0M$139.0M
Borrowings$52.0M$61.0M$40.0M$138.0M$111.0M$223.0M$295.0M$259.0M$295.0M$426.0M
Other Liabilities$42.0M$49.0M$53.0M$44.0M$73.0M$74.0M$78.0M$86.0M$113.0M$8.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$188.0M$205.0M$216.0M$240.0M$276.0M$296.0M$316.0M$476.0M$489.0M$476.0M

For U.S. Physical Therapy, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $61.0M; free cash flow was positive in 10 of 10 years; financing activities used $25.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$51.0M$57.0M$73.0M$62.0M$100.0M$76.0M$59.0M$82.0M$75.0M$75.0M
Investing Cash Flow−$41.0M−$51.0M−$31.0M−$48.0M−$59.0M−$132.0M−$90.0M−$54.0M−$159.0M−$51.0M
Financing Cash Flow−$7.0M−$8.0M−$16.0M−$16.0M−$4.0M−$31.0M−$17.0M−$16.0M−$15.0M−$25.0M
Net Cash Flow$4.0M$2.0M$1.0M$0$9.0M−$4.0M$3.0M$121.0M−$111.0M−$6.0M
Free Cash Flow$43.0M$49.0M$66.0M$52.0M$92.0M$68.0M$50.0M$73.0M$66.0M$61.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.47
EV / EBITDA18.37
FCF Yield4.69%
Quick Ratio1.42
Interest Coverage7.04
Return 1Y43.46%
Return 3Y22.01%
Return 5Y10.55%

U.S. Physical Therapy, Inc. (USPH) financials — frequently asked questions

What is U.S. Physical Therapy, Inc.'s annual revenue?

U.S. Physical Therapy, Inc. (USPH) reported annual revenue of $781.0M in its most recent fiscal year.

What is U.S. Physical Therapy, Inc.'s net profit?

U.S. Physical Therapy, Inc. (USPH) reported net profit of $15.0M in its most recent fiscal year.

What is USPH EV/EBITDA?

U.S. Physical Therapy, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 18.37.

Revenue and earnings of other Medical - Care Facilities stocks

HCA revenue $75.6BTHC revenue $21.3BEHC revenue $5.9BDVA revenue $13.6BENSG revenue $5.1BUHS revenue $17.4BCHE revenue $2.5BLFST revenue $1.4BOPCH revenue $5.7BHIMS revenue $2.3BAll Medical - Care Facilities stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
USPH Overview USPH Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.